Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma.

Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma.

The outcomes of patients treated with surgery for early stage pancreatic ductal adenocarcinoma (PDAC) are variable with median survival ranging from 6 months to more than 5 years. This challenge underscores an unmet need for developing personalized medicine strategies to refine the current treatment...

Full description

Bibliographic Details
Main Authors:	Dung-Tsa Chen, Ashley H Davis-Yadley, Po-Yu Huang, Kazim Husain, Barbara A Centeno, Jennifer Permuth-Wey, Jose M Pimiento, Mokenge Malafa
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4527782?pdf=render

Similar Items

A Phase I Safety, Pharmacokinetic, and Pharmacodynamic Presurgical Trial of Vitamin E δ-tocotrienol in Patients with Pancreatic Ductal Neoplasia
by: Gregory M. Springett, et al.
Published: (2015-12-01)

Comparison of Radiomic Features in a Diverse Cohort of Patients With Pancreatic Ductal Adenocarcinomas
by: Jennifer B. Permuth, et al.
Published: (2021-07-01)

Murine pancreatic adenocarcinoma reduces Ikaros expression and disrupts T cell homeostasis.
by: Nadine Nelson, et al.
Published: (2015-01-01)

Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma
by: David T. Pointer, et al.
Published: (2020-08-01)

Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
by: Chelsae R. Watters, et al.
Published: (2025-03-01)

Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
by: Min Ren, et al.
Published: (2023-08-01)

Vitamin E δ-tocotrienol induces p27(Kip1)-dependent cell-cycle arrest in pancreatic cancer cells via an E2F-1-dependent mechanism.
by: Pamela J Hodul, et al.
Published: (2013-01-01)

Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma
by: Andrea N. Riner, et al.
Published: (2024-02-01)

Metabolic signatures in pancreatic ductal adenocarcinoma: diagnostic and therapeutic implications
by: Ruining Gong, et al.
Published: (2023-12-01)

Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma
by: Julie Schnipper, et al.
Published: (2020-10-01)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
by: Rong Tang, et al.
Published: (2021-03-01)

Farnesyl dimethyl chromanol targets colon cancer stem cells and prevents colorectal cancer metastasis
by: Kazim Husain, et al.
Published: (2021-01-01)

Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors
by: Hao Liu, et al.
Published: (2016-11-01)

Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma
by: Feng Shao, et al.
Published: (2018-06-01)

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
by: Apeksha Kakkar, et al.
Published: (2016-12-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal Adenocarcinoma
by: Wenjing Song, et al.
Published: (2021-06-01)

Genome-Wide Profiling Reveals the Landscape of Prognostic Alternative Splicing Signatures in Pancreatic Ductal Adenocarcinoma
by: Chengkun Yang, et al.
Published: (2019-06-01)

A Long Non-coding RNA Signature to Improve Prognostic Prediction of Pancreatic Ductal Adenocarcinoma
by: Chenhao Zhou, et al.
Published: (2019-11-01)

A novel autoantibody signatures for enhanced clinical diagnosis of pancreatic ductal adenocarcinoma
by: Tiandong Li, et al.
Published: (2023-11-01)

The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma
by: Hao Lu, et al.
Published: (2022-09-01)

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
by: Weijia Wang, et al.
Published: (2021-02-01)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
by: Raffaele Pezzilli, et al.
Published: (2011-07-01)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
by: Wang, L, et al.
Published: (2015)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
by: Yizhi Wang, et al.
Published: (2020-09-01)

Pancreatic ductal adenocarcinoma: Prognostic indicators of advanced disease
by: Deirdré Kruger, et al.
Published: (2022-01-01)

Establishment and validation of a prognostic signature for pancreatic ductal adenocarcinoma based on lactate metabolism-related genes
by: Xin Huang, et al.
Published: (2023-06-01)

Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma
by: Zengyu Feng, et al.
Published: (2020-09-01)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
by: Zengyu Feng, et al.
Published: (2021-05-01)

Prognostic significance of collagen signatures in pancreatic ductal adenocarcinoma obtained from second-harmonic generation imaging
by: Xiwen Chen, et al.
Published: (2024-05-01)

The T cell architecture of pancreatic ductal adenocarcinoma
by: Sivakumar, S, et al.
Published: (2019)

The T-cell architecture of pancreatic ductal adenocarcinoma
by: Sivakumar, S, et al.
Published: (2019)

Ubiquitin signaling in pancreatic ductal adenocarcinoma
by: Shengnan Lv, et al.
Published: (2023-12-01)

Molecular imaging of pancreatic ductal adenocarcinoma
by: Wei Huang, et al.
Published: (2023-10-01)

Oral mycobiota and pancreatic ductal adenocarcinoma
by: Ailin Wei, et al.
Published: (2022-12-01)

Apoptotic pathways in pancreatic ductal adenocarcinoma
by: Saur Dieter, et al.
Published: (2008-07-01)

Metabolism remodeling in pancreatic ductal adenocarcinoma
by: Jin-Tao Li, et al.
Published: (2019-11-01)

Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
by: Sofia Parrasia, et al.
Published: (2021-01-01)

Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma
by: Lishan Fang, et al.
Published: (2023-01-01)

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
by: Huanwen Wu, et al.
Published: (2022-11-01)